Evidence mapPaperPMID 40788133Full record

ReviewInfection and immunity2025

Breaking down barriers: is intestinal mucus degradation by

Anna M Tingler, Melinda A Engevik

Abstract readReview
In one paragraph

Review in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Unveiling the Molecular Repertoire ofJournal of microbiology and biotechnology · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Nutrients · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anna M TinglerDepartment of Regenerative Medicine & Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0009-0006-8851-7080
Melinda A EngevikDepartment of Regenerative Medicine & Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-9742-9932

Funding

Cellular, Biochemical and Molecular Sciences Training ProgramT32GM132055 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2024 to 2025
$1.3M
Exploring the complex interactions between gut microbes and mucusR35GM155451 · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2025 to 2025
$378k
NIDDK NIH HHS T32GM132055NIGMS NIH HHS R35 GM155451NIGMS NIH HHS R35GM155451NIGMS NIH HHS T32 GM132055
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AkkermansiaGastrointestinal MicrobiomeIntestinal MucosaMucinsVerrucomicrobiaAnimalsHumansMucinsbacteriaglycanglycosyl hydrolasesmucinmucus

Identifiers

PMID40788133
PMCPMC12418764

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.